Letter to the Editor
Bone Marrow Transplantation advance online publication 14 July 2008; doi: 10.1038/bmt.2008.200
Treatment of adult AML with t(6;11)(q27;q23) by allogeneic hematopoietic SCT (Allo-HSCT) in the first CR
H Tamai1, H Yamaguchi1, S Takahashi2, A Tojo2, H Hamaguchi3, T Kobayashi4, H Akiyama4, H Sakamaki4, H Okumura5, Si Nakao5, A Arai6, O Miura6, K Tajika1, K Inokuchi1 and K Dan1
- 1Department of Hematology, Nippon Medical School, Tokyo, Japan
- 2Department of Hematology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
- 3Department of Hematology, Musashino Red Cross Hospital, Tokyo, Japan
- 4Department of Hematology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan
- 5Department of Hematology, Kanazawa University, Ishikawa, Japan
- 6Department of Hematology, Tokyo Medical and Dental University, Tokyo, Japan
Correspondence: H Tamai, E-mail: s6056@nms.ac.jp
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
RESEARCH
Cerebral accumulation of Tc-99m ethyl cysteinate dimer (ECD) in severe, transient hypothyroidism
Journal of Cerebral Blood Flow & Metabolism Original Article
Journal of Cerebral Blood Flow & Metabolism Original Article
Leukemia Letter
Leukemia Letter
